Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey

Sadeleştirilmiş öğe sayfası
dc.contributor.authorDemirci, Umut
dc.contributor.authorGokmen, Erhan
dc.contributor.authorEralp, Yesim
dc.contributor.authorGunduz, Seyda
dc.contributor.authorGoksu, Sema Sezgin
dc.contributor.authorKorkmaz, Taner
dc.contributor.authorKostek, Osman
dc.contributor.authorTurhal, Serdar
dc.contributor.authorPaydas, Semra
dc.contributor.authorTopcu, Sevgi
dc.contributor.authorCakar, Burcu
dc.contributor.authorKarabulut, Bulent
dc.contributor.authorTanriverdi, Ozgur
dc.contributor.authorKaraca, Burcak
dc.contributor.authorDeniz, Gulhan Ipek
dc.contributor.authorAlan, Ozkan
dc.contributor.authorTurkoz, Fatma Paksoy
dc.contributor.authorBasaran, Gul
dc.date.accessioned2025-10-16T15:21:55Z
dc.date.issued2020
dc.description.abstract42nd Annual San Antonio Breast Cancer Symposium, San Antonio, TX, DEC 09-14, 2019
dc.identifier.doi10.1158/1538-7445.SABCS19-P5-11-19
dc.identifier.otherWOS:000527012503011
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7753
dc.publisherAMER ASSOC CANCER RESEARCH
dc.sourceCANCER RESEARCH
dc.titleRibociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS